Using Positive Controls to Define the Defect Detection Range for CCIT Method Development and Validation.

Q3 Medicine
Ken Victor, Allison Alix Caudill, Peter Grant, Inese Jermakova, James Veale
{"title":"Using Positive Controls to Define the Defect Detection Range for CCIT Method Development and Validation.","authors":"Ken Victor, Allison Alix Caudill, Peter Grant, Inese Jermakova, James Veale","doi":"10.5731/pdajpst.2025-000071.1","DOIUrl":null,"url":null,"abstract":"<p><p>In recent years, the pharmaceutical industry has moved towards using quality by design (QbD) principles to ensure safety and efficacy in parenteral products. Developing and validating container closure integrity test (CCIT) methods that can be used to confirm inherent package integrity - as well as batch-release and stability sample testing - is an essential aspect of this more holistic approach. To do so, both positive and negative controls are required, both of which should ideally be assembled with container components in a manner mimicking the production samples that are to be tested. The performance of these controls enables the accuracy, precision, limit of detection (LoD), and range of the CCIT method to be defined per the ICH Q2 parameters [1]. The negative controls should contain no known defect. The positive controls should differ from the negative controls only in that they have a well-characterized defect that creates a quantified breach in the container closure integrity (CCI) of the package assembly. When appropriate, \"type controls,\" as defined in USP <1207>, can also be included during CCIT method development [2]. Type controls are intended to qualitatively evaluate the ability of the CCIT method to identify defects that better mimic \"real-world\" defects, including the potential of the product to inhibit the identification of such defects.The first objective of this study was to present a theoretical framework that links the flow-effective size [3] parameterization with the observed gas flow rates for a defect. The second objective was to demonstrate the use of microcapillaries to create defects with a flow-effective size much smaller than the current 2 μm limit of laser-drilled defects. The third objective was to reveal that the flow-effective size associated with 5 and 10 μm laser-drilled defects in glass vials decreased significantly when submerged below a liquid 0.2 μm filtered-water fill.</p>","PeriodicalId":19986,"journal":{"name":"PDA Journal of Pharmaceutical Science and Technology","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2026-06-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"PDA Journal of Pharmaceutical Science and Technology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5731/pdajpst.2025-000071.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

In recent years, the pharmaceutical industry has moved towards using quality by design (QbD) principles to ensure safety and efficacy in parenteral products. Developing and validating container closure integrity test (CCIT) methods that can be used to confirm inherent package integrity - as well as batch-release and stability sample testing - is an essential aspect of this more holistic approach. To do so, both positive and negative controls are required, both of which should ideally be assembled with container components in a manner mimicking the production samples that are to be tested. The performance of these controls enables the accuracy, precision, limit of detection (LoD), and range of the CCIT method to be defined per the ICH Q2 parameters [1]. The negative controls should contain no known defect. The positive controls should differ from the negative controls only in that they have a well-characterized defect that creates a quantified breach in the container closure integrity (CCI) of the package assembly. When appropriate, "type controls," as defined in USP <1207>, can also be included during CCIT method development [2]. Type controls are intended to qualitatively evaluate the ability of the CCIT method to identify defects that better mimic "real-world" defects, including the potential of the product to inhibit the identification of such defects.The first objective of this study was to present a theoretical framework that links the flow-effective size [3] parameterization with the observed gas flow rates for a defect. The second objective was to demonstrate the use of microcapillaries to create defects with a flow-effective size much smaller than the current 2 μm limit of laser-drilled defects. The third objective was to reveal that the flow-effective size associated with 5 and 10 μm laser-drilled defects in glass vials decreased significantly when submerged below a liquid 0.2 μm filtered-water fill.

用正控制定义CCIT方法开发和验证的缺陷检测范围。
近年来,制药行业已经转向使用质量设计(QbD)原则,以确保注射产品的安全性和有效性。开发和验证容器封闭完整性测试(CCIT)方法,可用于确认固有的包装完整性-以及批放行和稳定性样品测试-是这种更全面的方法的一个重要方面。为此,需要阳性对照和阴性对照,理想情况下,这两种对照都应以模仿待测生产样品的方式与容器组件组装在一起。这些控制的性能使CCIT方法的准确度、精密度、检测限(LoD)和范围能够根据ICH Q2参数[1]进行定义。阴性控制应该不包含已知缺陷。阳性控制与阴性控制的不同之处在于,它们具有明显的缺陷,会在包装组件的容器封闭完整性(CCI)中产生量化的破坏。在适当的时候,USP中定义的“类型控制”也可以包括在CCIT方法开发过程中。类型控制旨在定性地评估CCIT方法识别更好地模拟“真实世界”缺陷的能力,包括产品抑制识别此类缺陷的潜力。本研究的第一个目标是提出一个理论框架,将流动有效尺寸[3]参数化与观察到的缺陷气体流速联系起来。第二个目标是演示利用微血管制造的缺陷,其流动有效尺寸远小于目前激光钻孔缺陷的2 μm限制。第三个目标是揭示当淹没在0.2 μm过滤水填充液下时,玻璃小瓶中与5和10 μm激光钻孔缺陷相关的流动有效尺寸显着减小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
1.90
自引率
0.00%
发文量
34
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书